Gary E. Duncan

Overview

Best Publications

• Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

  Seiya Miyamoto;Gary E Duncan;Christine E Marx;Jeffrey A Lieberman

  1315
  Citations

• Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety.

  Gary E. Duncan;Darin J. Knapp;George R. Breese

  468
  Citations

• Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity

  GE Duncan;KB Johnson;GR Breese

  338
  Citations

• Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding.

  U.B. Schambra;G.E. Duncan;G.R. Breese;M.G. Fornaretto

  308
  Citations

• Serotonergic basis of antipsychotic drug effects in schizophrenia

  Jeffrey A Lieberman;Richard B Mailman;Gary Duncan;Lin Sikich

  303
  Citations

• 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

  G R Breese;G E Duncan;T C Napier;S C Bondy

  301
  Citations

• Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

  Gary E Duncan;Sheryl S Moy;Antonio Perez;Dawn M Eddy

  280
  Citations

• Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

  Jeffrey A. Lieberman;Frank P. Bymaster;Herbert Y. Meltzer;Ariel Y. Deutch

  264
  Citations

• An integrated view of pathophysiological models of schizophrenia.

  Gary E Duncan;Brian B Sheitman;Jeffery A Lieberman

  240
  Citations

• Development of a mouse test for repetitive, restricted behaviors: relevance to autism.

  Sheryl S. Moy;Jessica J. Nadler;Michele D. Poe;Randal J. Nonneman

  221
  Citations

• Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.

  H E Criswell;P E Simson;G E Duncan;T J McCown

  207
  Citations

• Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

  Gary E Duncan;Sheryl S Moy;Darin J Knapp;Robert A Mueller

  191
  Citations

• Cocaine use increases [3H]WIN 35428 binding sites in human striatum

  Little Ky;Kirkman Ja;Carroll Fi;Clark Tb

  185
  Citations

• Recent advances in the neurobiology of schizophrenia.

  Seiya Miyamoto;Anthony S. LaMantia;Gary E. Duncan;Patrick Sullivan

  178
  Citations

• Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity.

  Gary E. Duncan;Darin J. Knapp;Kevin B. Johnson;George R. Breese

  159
  Citations

• Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

  Gary E Duncan;Seiya Miyamoto;Jeremy N Leipzig;Jeffery A Lieberman

  159
  Citations

• Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.

  Christine E Marx;Margaret J VanDoren;Gary E Duncan;Jeffrey A Lieberman

  154
  Citations

• Induction of Fos-Like Proteins and Ultrasonic Vocalizations during Ethanol Withdrawal: Further Evidence for Withdrawal-Induced Anxiety

  Darin J. Knapp;Gary E. Duncan;Fulton T. Crews;George R. Breese

  145
  Citations

• Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

  Gary E Duncan;Jeremy N Leipzig;Richard B Mailman;Jeffery A Lieberman

  139
  Citations

• Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.

  G E Duncan;H E Criswell;T J McCown;I A Paul

  137
  Citations